Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H21N6 |
Molecular Weight | 309.3888 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
CN1C(C)=C\C(=N\C2=CC3=C(N)C=C(C)[N+](C)=C3C=C2)N=C1N
InChI
InChIKey=KMJWBVJQFGRCEB-UHFFFAOYSA-O
InChI=1S/C17H20N6/c1-10-7-14(18)13-9-12(5-6-15(13)22(10)3)20-16-8-11(2)23(4)17(19)21-16/h5-9,18H,1-4H3,(H2,19,20,21)/p+1
Molecular Formula | C17H20N6 |
Molecular Weight | 308.3809 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Uridine 5'-diphosphate glucose analogues. Inhibitors of protein glycosylation that show antiviral activity. | 1985 Jan |
|
Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia. | 1988 Jun |
|
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii. | 1995 Nov 24 |
|
Antibody levels by indirect ELISA test in Trypanosoma evansi infected horses following treatment with quinapyramine sulphate. | 2003 Jan 20 |
|
The history of African trypanosomiasis. | 2008 Feb 12 |
|
Health management of horses under high challenge from trypanosomes: a case study from Serengeti, Tanzania. | 2008 Jul 4 |
|
Development and application of an antibody-ELISA to follow up a Trypanosoma evansi outbreak in a dromedary camel herd in France. | 2009 Jun 10 |
|
Genotypic status of the TbAT1/P2 adenosine transporter of Trypanosoma brucei gambiense isolates from Northwestern Uganda following melarsoprol withdrawal. | 2009 Sep 29 |
|
Immunobiology of African trypanosomes: need of alternative interventions. | 2010 |
|
Studies of quinapyramine-resistance of Trypanosoma brucei evansi in China. | 2010 Dec |
|
Proteomics of Trypanosoma evansi infection in rodents. | 2010 Mar 22 |
|
In vitro activity and preliminary toxicity of various diamidine compounds against Trypanosoma evansi. | 2010 May 11 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:40:25 GMT 2023
by
admin
on
Sat Dec 16 05:40:25 GMT 2023
|
Record UNII |
B2NT1100WR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QP51AX20
Created by
admin on Sat Dec 16 05:40:25 GMT 2023 , Edited by admin on Sat Dec 16 05:40:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
B2NT1100WR
Created by
admin on Sat Dec 16 05:40:25 GMT 2023 , Edited by admin on Sat Dec 16 05:40:25 GMT 2023
|
PRIMARY | |||
|
122993
Created by
admin on Sat Dec 16 05:40:25 GMT 2023 , Edited by admin on Sat Dec 16 05:40:25 GMT 2023
|
PRIMARY | |||
|
20493-41-8
Created by
admin on Sat Dec 16 05:40:25 GMT 2023 , Edited by admin on Sat Dec 16 05:40:25 GMT 2023
|
PRIMARY | |||
|
m9438
Created by
admin on Sat Dec 16 05:40:25 GMT 2023 , Edited by admin on Sat Dec 16 05:40:25 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000141676
Created by
admin on Sat Dec 16 05:40:25 GMT 2023 , Edited by admin on Sat Dec 16 05:40:25 GMT 2023
|
PRIMARY | |||
|
QUINAPYRAMINE
Created by
admin on Sat Dec 16 05:40:25 GMT 2023 , Edited by admin on Sat Dec 16 05:40:25 GMT 2023
|
PRIMARY | |||
|
48223
Created by
admin on Sat Dec 16 05:40:25 GMT 2023 , Edited by admin on Sat Dec 16 05:40:25 GMT 2023
|
PRIMARY | |||
|
DTXSID90942667
Created by
admin on Sat Dec 16 05:40:25 GMT 2023 , Edited by admin on Sat Dec 16 05:40:25 GMT 2023
|
PRIMARY | |||
|
64215-84-5
Created by
admin on Sat Dec 16 05:40:25 GMT 2023 , Edited by admin on Sat Dec 16 05:40:25 GMT 2023
|
ALTERNATIVE | |||
|
SUB96098
Created by
admin on Sat Dec 16 05:40:25 GMT 2023 , Edited by admin on Sat Dec 16 05:40:25 GMT 2023
|
PRIMARY | |||
|
1082114-38-2
Created by
admin on Sat Dec 16 05:40:25 GMT 2023 , Edited by admin on Sat Dec 16 05:40:25 GMT 2023
|
ALTERNATIVE |